Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Stadler

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IBTeresa Amaral, Lena Nanz, Rudolf Stadler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)Rudolf Stadler, Pablo Ortiz Romero, Martine Bagot, et al.
Archives of Dermatology|November 23, 2006
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigusStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Human Genetics|December 17, 2002
Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab EmiratesKatja Martina Eckl, Howard P Stevens, Gilles G Lestringant, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 31, 2007
Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)Chalid Assaf, Sylke Gellrich, Matthias Steinhoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell LymphomaSebastian Theurich, Max Schlaak, Harold Steguweit, et al.
Archives of Dermatology|December 19, 2007
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoidStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Journal of the American Academy of Dermatology|March 16, 2021
Quality of life in patients with mycosis fungoides and Sézary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapyTarek Nawar, Khaled Elsayad, Elisa Christina Müller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practiceClaus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2024
Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IBTeresa Amaral, Lena Nanz, Rudolf Stadler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2021
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb-IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)Rudolf Stadler, Pablo Ortiz Romero, Martine Bagot, et al.
Archives of Dermatology|November 23, 2006
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigusStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Human Genetics|December 17, 2002
Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab EmiratesKatja Martina Eckl, Howard P Stevens, Gilles G Lestringant, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 31, 2007
Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)Chalid Assaf, Sylke Gellrich, Matthias Steinhoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell LymphomaSebastian Theurich, Max Schlaak, Harold Steguweit, et al.
Archives of Dermatology|December 19, 2007
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoidStefan Beissert, Thomas Werfel, Uta Frieling, et al.
Journal of the American Academy of Dermatology|March 16, 2021
Quality of life in patients with mycosis fungoides and Sézary syndrome undergoing low-dose total skin electron beam therapy with or without maintenance therapyTarek Nawar, Khaled Elsayad, Elisa Christina Müller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practiceClaus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
Pageof 15